Key result
Review links Chlamydia pneumoniae infection and lipid metabolism interactions across key areas of atherosclerosis pathogenesis.
Answers are grounded in this paper and cite their sources.
Coronary artery disease is a multifactorial condition, and the putative role of any emerging risk factor for the disease must be considered in the context of well-defined risk factors. This workshop group focused on the interaction between Chlamydia pneumoniae infection and lipid metabolism in the pathogenesis of atherosclerosis. Five major categories of issues that should be considered when examining C. pneumoniae—lipid metabolism interactions were identified: (1) defined risk factors possibly influenced by C. pneumoniae infection, (2) pathogenic mechanisms that may be affected by C. pneumoniae, (3) identification of putative bacterial virulence determinants, (4) methods of lipoprotein isolation for use in these studies, and (5) choice of an appropriate control mechanism for these studies. Furthermore, four areas for possible future research were identified: (1) understanding the role of latent infection in lipid metabolism, (2) identifying molecular mechanisms that may modify C. pneumoniae—lipid metabolism interactions, (3) designing specific lipoprotein studies, and (4) designing genomic and genetic studies to elucidate the interactions between infection and lipid metabolism. Major risk factors that predict the development of coronary artery disease include low levels of high-density lipoprotein, increased levels of low-density lipoprotein (LDL), and increased levels of very low-density lipoprotein. Changes in lipoprotein profiles that predict the atherogenic state may be induced by infection, and the role of C. pneumoniae infection in influencing atherogenic lipoprotein profiles is being addressed. However, it also is important to consider new lipoprotein subclasses, such as small, dense LDL, when examining a putative role for C. pneumoniae infection. To this end, methods for isolation and analysis of lipoprotein classes and subclasses must be consistent when examining C. pneumoniae—lipid interactions. Mechanisms that may contribute directly or indirectly to atherogenesis include uptake of native or modified lipoproteins by cell types present in atheromatous lesions, processing and retention of intracellular lipids, and reverse cholesterol transport from atheroma cells. C. pneumoniae may influence any of these steps through interactions with monocytes/macrophages, endothelial cells, and smooth muscle cells. Identification of molecular mechanisms whereby C. pneumoniae may influence such interactions is important for identifying a role for infection in the disease process. For example, C. pneumoniae can interact with monocytes/macrophages to induce LDL accumulation and LDL oxidation. Does C. pneumoniae also interfere with modification of intracellular cholesterol levels or with reverse cholesterol transport? Identification of C. pneumoniae virulence determinants that may be involved in these interactions will be important to define mechanisms of atherogenesis. The workshop group identified lipopolysaccharide, heat shock protein 60, and outer membrane proteins (pomps) as candidates that may influence C. pneumoniae—lipid interactions. The working group also discussed appropriate controls for these studies. Chlamydia trachomatis and LPS or heat shock proteins from other microorganisms can be used to determine how C. pneumoniae may be unique in contributing to atherogenesis. Future research may focus on how latent infection can influence lipid metabolism. In vivo, sites of latency at the organ, tissue, and cellular levels can be identified and correlated with modifications in lipid levels. Factors that influence permissiveness for infection, establishment of latency, and reactivation of infection in all cell types present in the atheroma can be characterized. Molecular mechanisms by which C. pneumoniae may augment or exacerbate hyperlipidemic states can be considered. Furthermore, the manner in which C. pneumoniae directly interacts with lipoproteins can be examined. This includes elucidation of lipoprotein modification pathways after infection and determining if lipid-loaded cells modulate specific receptors that influence C. pneumoniae infection. Virulence determinants and their specific host cell receptors that influence C. pneumoniae—lipid interactions also should be elucidated. It is important to examine all cell types present in the atheroma since each of these cell types is susceptible to C. pneumoniae infection and can interact with lipoproteins. Appropriate animal models that are susceptible to infection and have a lipid profile that resembles that of humans should be developed. Genomic and genetic studies that use microarray technology to study chlamydial and host cell gene expression may be a rewarding future area of research to understand C. pneumoniae—lipid interactions in the pathogenesis of atherosclerosis. On the basis of the preceding discussion, the workshop panel made the following recommendations for research directions in four major categories: Biology of latency and infection Identify and study in vivo sites of latency at the organ, tissue, and cellular levels. Characterize conditions and factors controlling permissiveness for infection, establishment of latency, and reactivation of productive infection in macrophages, endothelium, smooth muscle cells, and other cell types relevant to atherosclerosis. Molecular mechanisms of pathogenesis Study specific mechanisms by which C. pneumoniae might augment or exacerbate risk factors such as hypercholesterolemia. Study the molecular interactions that mediate the regulation of the host inflammatory response to infection and the role of these interactions in the etiology, incidence, and severity of atherosclerosis. Lipoprotein studies Study the modification of lipoproteins by C. pneumoniae. Elucidate pathways involved in the modification of lipoproteins. Develop better isolation methods for lipoproteins. Study lipoprotein receptor modulation by C. pneumoniae. Study effects of C. pneumoniae on other vascular cells, such as smooth muscle cells and endothelial cells. Use appropriate animal models to understand susceptibility to C. pneumoniae infection and construct lipid ratios and lipid profiles similar to those found in humans. Genomic/genetic studies Identify and characterize regulatory regions of C. pneumoniae for virulence factor expression. Use microarray technology to study chlamydial and host cell gene expression. Determine the influence of host genetics on the pathogenesis of C. pneumoniae infection. Study epidemiologic associations between hyperlipidemic states and C. pneumoniae infection.
No takes yet. Share an insight, caveat, or question.
Byrne et al. (2000) conducted a review in Atherosclerosis and coronary artery disease. Chlamydia pneumoniae infection was evaluated. Chlamydia pneumoniae infection interactions with lipid metabolism were evaluated across 5 issue categories and 4 research areas for atherosclerosis pathogenesis.
Synapse has enriched 10 related papers. Consider them for comparative context: